TY - JOUR
T1 - Diabetes Research Matters
T2 - A Three-Round Priority-Setting Survey Consultation with Adults Living with Diabetes and Family Members in Australia
AU - Hendrieckx, Christel
AU - Russell-Green, Sienna
AU - Skinner, Timothy
AU - Ng, Ashley H.
AU - Lee, Chris
AU - Barlow, Siobhan
AU - Davey, Alan
AU - Rogers, Caitlin
AU - Holmes-Truscott, Elizabeth
AU - Speight, Jane
N1 - Funding Information:
This research was funded by a General Grant awarded by the Diabetes Australia Research Program (DARP). Christel Hendrieckx, Elizabeth Holmes-Truscott and Jane Speight are supported by the core funding to the Australian Centre for Behavioural Research in Diabetes provided by the collaboration between Diabetes Victoria and Deakin University.
Funding Information:
Diabetes is a global health priority, presenting a significant challenge to the health and well-being of individuals living with the condition, their families and societies [, ]. In Australia, more than 1.5 million people have diabetes, with around 9% with type 1 diabetes (T1D), 85% with type 2 diabetes (T2D) and 3% with gestational diabetes mellitus (GDM) []. In 2018–19, the direct diabetes costs to the Australian health system were estimated at $3 billion, with 40% spent on hospital services []. Australian diabetes research is funded mostly by government bodies (e.g. National Health and Medical Research Council, Medical Research Future Fund []) and peak organisations (e.g. Juvenile Diabetes Research Foundation, Diabetes Australia). Over the past decade, the National Health and Medical Research Council funding for diabetes research exceeded AUD$500 million (~9% total funding) []. To date, the Medical Research Future Fund has invested more than AUD$100 million in diabetes research projects []. However, in Australia [, ] and worldwide, diabetes research remains underfunded, relative to some other conditions [–], and particularly so for behavioural and psychosocial research []. Thus, it is imperative that limited research funding responds directly to the needs and interests of the community living with diabetes. In contrast, a disparity may exist between funded research and the priorities of those with the condition [].
Publisher Copyright:
© The Author(s) 2024.
PY - 2024/7
Y1 - 2024/7
N2 - Objective: We aimed to identify the health and quality-of-life research priorities of Australians with diabetes or family members. Methods: Through an iterative, three-step, online survey process we (1) qualitatively generated research topics (long list) in response to one question “What research is needed to support people with diabetes to live a better life?”; (2) determined the most important research questions (short list); and (3) ranked research questions in order of importance (priorities). We aimed to recruit N = 800 participants, with approximate equal representation of diabetes type and family members. Results: Participants (N = 661) were adults (aged 18+ years) in Australia with a self-reporting diagnosis of diabetes (type 1, n = 302; type 2, n = 204; prior/current gestational, n = 58; less common types, n = 22, or a family member, n = 75). Retention rates for Surveys 2 and 3 were 47% (n = 295) and 50% (n = 316), respectively. From 1549 open-text responses, 25 topics and 125 research questions were identified thematically. Research priorities differed by cohort, resulting in specific lists developed and ranked by each cohort. The top-ranked research question for the type 1 diabetes cohort was “How can diabetes technology be improved …?” and for the type 2 diabetes cohort: “How can insulin resistance be reversed …?”. One question was common to the final lists of all cohorts: “What are the causes or triggers of diabetes?” Within cohorts, the top priorities were perceived as being of similar importance. Conclusions: The research priorities differ substantially by diabetes type and for family members. These findings should inform funding bodies and researchers, to align future research and its communication with community needs.
AB - Objective: We aimed to identify the health and quality-of-life research priorities of Australians with diabetes or family members. Methods: Through an iterative, three-step, online survey process we (1) qualitatively generated research topics (long list) in response to one question “What research is needed to support people with diabetes to live a better life?”; (2) determined the most important research questions (short list); and (3) ranked research questions in order of importance (priorities). We aimed to recruit N = 800 participants, with approximate equal representation of diabetes type and family members. Results: Participants (N = 661) were adults (aged 18+ years) in Australia with a self-reporting diagnosis of diabetes (type 1, n = 302; type 2, n = 204; prior/current gestational, n = 58; less common types, n = 22, or a family member, n = 75). Retention rates for Surveys 2 and 3 were 47% (n = 295) and 50% (n = 316), respectively. From 1549 open-text responses, 25 topics and 125 research questions were identified thematically. Research priorities differed by cohort, resulting in specific lists developed and ranked by each cohort. The top-ranked research question for the type 1 diabetes cohort was “How can diabetes technology be improved …?” and for the type 2 diabetes cohort: “How can insulin resistance be reversed …?”. One question was common to the final lists of all cohorts: “What are the causes or triggers of diabetes?” Within cohorts, the top priorities were perceived as being of similar importance. Conclusions: The research priorities differ substantially by diabetes type and for family members. These findings should inform funding bodies and researchers, to align future research and its communication with community needs.
UR - https://www.scopus.com/pages/publications/85189286852
U2 - 10.1007/s40271-024-00688-5
DO - 10.1007/s40271-024-00688-5
M3 - Article
C2 - 38582797
AN - SCOPUS:85189286852
SN - 1178-1653
VL - 17
SP - 441
EP - 455
JO - The Patient - Patient-Centered Outcomes Research
JF - The Patient - Patient-Centered Outcomes Research
IS - 4
ER -